Mechanism of Metronidazole Resistance Regulated by the fdxA Gene in Helicobacter pylori.
![]() |
Nam, Won-Hee
(Asan Institute for Life Sciences, University of Ulsan College of Medicine)
Lee, Sun-Mi (Asan Institute for Life Sciences, University of Ulsan College of Medicine) Kim, Eun-Sil (Asan Institute for Life Sciences, University of Ulsan College of Medicine) Kim, Jin-Ho (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Jeong, Jin-Yong (Asan Institute for Life Sciences, University of Ulsan College of Medicine) |
1 | Rhee, K. H., H. S. Youn, S. C. Baik, W. K. Lee, M. J. Cho, H. J. Choi, K. Y. Maeng and K. W. Ko. 1990. Prevalence of Helicobacter pylori Infection in Korea. J. Korean Soc. Microbiol. 25, 475-490 |
2 | Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. Ketchum, H. Klenk, S. Gill, B. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. Khalak, A. Glodek, K. McKenney, L. Fitzegerald, N. Lee, M. Adams, E. Hickey, D. Berg, J. Gocayne, T. Utterback, J. Peterson, J. Kelley, M. Cotton, J. Weidman, C. Fujii, C. Bowman, L. Watthey, E. Wallin, W. Hayes, M. Borodovsky, P. Karp, H. Smith, C. Fraser and J. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388, 539-547 礙 돀태?⨀ 堘?⨀ 䁢⨀ 儙 돐 ?⨀ ?⨀ 聢⨀ ⤙ 댐 # Ȁ DOI ScienceOn |
3 | Wotherspoon, A. C. Gastric MALT lymphoma and Helicobacter pylori. Yale J. Biol. Med. 69, 61-68 |
4 | Jeong, J. Y. and D. E. Berg. 2000. Mouse-colonizing Helicobacter pylori SS1 is unusually susceptible to metronidazole due to two complementary reductase activities. Antimicrob. Agents Chemother. 44, 3127-3132 DOI ScienceOn |
5 | Kim, J. J., R. Reddy, M. Lee, J. G. Kim, F. A. El-Zaatari, M. S. Osato, D. Y. Graham and D. H. Kwon. 2001. Analysis of metronidazole, clarithromycin and tetracy¬cline resistance of Helicobacter pylori isolates from Korea. J. Antimicrob. Chemother. 47, 459-461 DOI ScienceOn |
6 | Knipp, U., S. Birkholz, W. Kaup and W. Opferkuch. 1993. Immune suppressive effects of Helicobacter pylori on hu¬man peripheral blood mononuclear cells. Med. Microbiol. Immunol. 182, 63-76 |
7 | Kwon, D. H., F. A. El-Zaatari, M. Kato, M. S. Osato, R. Reddy, Y. Yamaoka and D. Y. Graham. Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob. Agents Chemother. 44, 2133-42 DOI ScienceOn |
8 | Lingwood, C. A., G. Wasfy, H. Han and M. Huesca. 1993. Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori. Infect. Immun. 61, 2474-2478 |
9 | Malaty, H. M., L. Engstrand, N. L. Pedersen and D. Y. Graham. 1994. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann. Intern. Med. 120, 982-986 DOI ScienceOn |
10 | Moss, S. and J. Calam. 1992. Helicobacter pylori and peptic ulcers: the present position. Gut. 33, 289-92 DOI ScienceOn |
11 | Mukhopadhyay, A. K, J. Y. Jeong, D. Dailidiene, P. S. Hoffman and D. E. Berg. 2003. The fdxA ferredoxin gene can down-regulate frxA nitroreductase gene expression and is essential in many strains of Helicobacter pylori. J. Bacteriol. 185, 2927-2935 DOI ScienceOn |
12 | Graham, D. Y. 1997. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 113, 1983-1991 DOI ScienceOn |
13 | Chiba, N., B. V. Rao, J. W. Rademaker and R. H. Hunt. 1992. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am. J. Gastroenterol. 87, 1716-1727 |
14 | Edwards, D. I. 1993. Nitroimidazole drugs-action and resistance mechanisms. II. Mechanisms of resistance. J. Antimicrob. Chemother. 31, 201-210 DOI |
15 | Goodwin, C. S., J. A. Armstrong and B. J. Marshall. 1986. Campylobacter pyloridis, gastritis, and peptic ulceration. J. Clin. Pathol. 39, 353-365 DOI |
16 | Graham, D. Y. and Y. Yamaoka. 1998. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter 3, 145-151 DOI ScienceOn |
17 | Harris, A. 1998. Current regimens for treatment of Helicobacter pylori infection. Br. Med. Bull. 54, 195-205 DOI ScienceOn |
18 | Isaacson, P. G. and J. Spencer. 1993. Is gastric lymphoma an infectious disease? Hum. Pathol. 24, 569-570 DOI ScienceOn |
19 | Jeong, J. Y., A. K. Mukhopadhyay, D. Dailidiene, Y Wang, B. Velapatio, R. H. Gilman, A. J. Parkinson, G. B Nair, B. C. Y. Wong, S. K. Lam, R. Mistry, I. Segal, Y. Yuan, H. Gao, T. Alarcon, M. L. Brea, Y. Ito, D. Kersulyte, H.-K. Lee, Y. Gong, A. Goodwin, P. S. Hoffman and D. E. Berg. 2000. Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes cause moderate and high-level metronidazole resistance in Helicobacter pylori. J. Bacteriol. 182, 5082-5090 DOI ScienceOn |
20 | Jeong, J. Y., A. K. Mukhopadhyay, J. K. Akada, D. Dailidiene, P. S. Hoffman and D. E. Berg. 2001. Roles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole. J. Bacteriol. 183, 5155-5162 DOI ScienceOn |
21 | Andersen, L. P., S. Holck, C. O. Povlsen, L. Elsborg and T. Justesen. 1987. Campylobacter pyloridis in peptic ulcer disease. I. Gastric and duodenal infection caused by C. pyloridis: histopathologic and microbiologic findings. Scand. J. Gastroenterol. 22, 219-224 DOI ScienceOn |
![]() |